Impetus DigitalImpetus Digital Logo
AllClinical Trials4Controversial Therapies3Customer Success Stories11Digital Technologies11eBooks & Infographics12Future of Healthcare22Impetus Team10Improve Your Advisory Boards70Market Access17Oncology15Patient Engagement5Personalized Medicine4Pharma Headlines2Psychology of Digital Collaboration10Real-World Evidence3
Oncology Nurse Navigator Patient Journey Mapping

Oncology Nurse Navigator Patient Journey Mapping Customer Success Story

person
Natalie Yeadon
folder_openCustomer Success Stories, Oncology
In this Oncology Nurse Navigator customer success story, we summarize the results, outcomes, and benefits of using the Impetus InSite Platform® and Impetus’ content creation services for patient journey mapping—an interesting alternative use case of online advisory boards. In summary, our client engaged 8 oncology nurse navigators from across Canada to get their perspectives on…
Multiple Sclerosis RWE Working Group Customer Success Story

Multiple Sclerosis RWE Working Group Customer Success Story

person
Natalie Yeadon
folder_openCustomer Success Stories, Real-World Evidence
In this Multiple Sclerosis Real-World Evidence (RWE) customer success story, we summarize the results, outcomes, and benefits of using the Impetus InSite Platform® for consensus document co-creation. In brief, a government-sponsored working group comprising neurologists and academic researchers was tasked with developing a consensus document on the place of RWE in the treatment-decision algorithm for…
Tumor microenvironment

Targeting the Tumor Microenvironment

person
Natalie Yeadon
folder_openFuture of Healthcare, Oncology, Pharma Headlines
Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving field, with novel and experimental therapies such as cancer vaccines, CAR-T cells, and CRISPR frequently making the news. Recently, I came across preclinical research suggesting that targeting carbonic anhydrase 9 (“CA9” or “CAIX”), a hypoxia-induced pH…
In-Person Meeting Capabilities

Infographic: Our In-Person Meeting Capabilities

person
Natalie Yeadon
folder_openeBooks & Infographics, Impetus Team
Learn all about Impetus Digital’s unique In-Person Meeting Capabilities! We work closely with you to make the most out of your valuable face-to-face time with your advisors. Our services include Strategic Consulting, Advisor Discovery, Identification, Recruitment and Contracting, Project Management… We work closely with you to make the most out of your valuable face-to-face time…
global warming

Why Pharma Needs to Care About Global Warming

person
Natalie Yeadon
folder_openDigital Technologies, Future of Healthcare, Pharma Headlines
A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis”) being in the news. Last month, Europe experienced a record heatwave with temperatures reaching almost 46°C (115°F). This is literally unheard of. Earlier this year, reports from the…
patient adherence

Three Key Questions About Adherence/Compliance in 2019

person
Natalie Yeadon
folder_openDigital Technologies, Future of Healthcare, Patient Engagement
PM360 asked those with expertise in improving adherence/compliance, including Impetus’ Natalie Yeadon, what the keys to a successful program are, the impact of new tech, and examples to emulate. Specifically, they were asked to address: What are the best ways to design adherence programs to ensure you are addressing the biggest barriers to adherence for your…
Medical Device / Interventional Cardiology Advisory Board Customer Success Story

Medical Device Advisory Board: A Customer Success Story

person
Natalie Yeadon
folder_openCustomer Success Stories
In early 2019, our client—a Canadian team from a large Medical Device company—conducted a total of three online touchpoints before and after an in-person meeting facilitated by Impetus. By adding a pre-meeting online touchpoint, the interventional cardiology advisors were able to get familiarized with the materials to be presented, leaving more time for interactive discussions and…
adaptive design

Innovative Trial Designs for Individualizing Oncology Treatments – Part 2

person
Natalie Yeadon
folder_openClinical Trials, Future of Healthcare, Oncology, Personalized Medicine
Last month, I looked into adaptive trials for individualizing oncology treatment and moving towards personalized medicine. In part 2 of 2 of this series, I’m discussing more specific adaptive clinical trial designs, including umbrella, basket, and N-of-1 trials. For study sponsors and investigators alike, getting familiar with these adaptive trial designs is important to ensure…
Clinical Trial Collaboration

Clinical Trial Collaboration: An Oncology Customer Success Story

person
Natalie Yeadon
folder_openClinical Trials, Customer Success Stories, Oncology
In this Oncology Phase III Clinical Trial customer success story, we summarize the results and benefits of using our Pharma-compliant platform for ongoing communication and collaboration between investigator teams at different study sites. This project was initiated in 2016 and is ongoing. To date, our client – a large pharmaceutical company based in western Europe…
Load More
Menu